MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0074559
Ranq Remedies Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹51.82 Cr
▲ 6% YoY
Net profit · FY 2025
₹5.05 Cr
Net margin 9.7%
EBITDA · FY 2025
₹8.21 Cr
EBITDA margin 15.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Satisfied charges
₹22 Cr
No open charges
Company age
24 yrs
Est. 2002
Employees · EPFO
59
Provident fund records
About Ranq Remedies Private Limited
Data last updated:
Ranq Remedies Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 September 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2002PTC137303. Its GSTIN is 27AACCR4662E1ZF (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sameer Gajanan Ranadive and Janhavi Bhargav Jangle.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ganatra Complexd 112 Next To Punjani Estate Khopat, Thane, Maharashtra, India – 400601.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.82 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.05 Cr (net margin 9.7%) and EBITDA of ₹8.21 Cr (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
The company has about 59 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹22 Cr on record. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 2 cases are pending.
Ranq Remedies Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0074559). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website microcellulose.com.
Company details
CIN U24230MH2002PTC137303
Registration Number 137303
Incorporation Date 20 September 2002
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0074559
Recognitions & Rankings of Ranq Remedies
Contact details
Ranq Remedies Private Limited's registered office is in Thane, Maharashtra. Its website is microcellulose.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGanatra Complexd 112 Next To Punjani Estate Khopat, Thane, Maharashtra, India – 400601
- IndustryPharma, API Manufacturers
To see the full contact details of Ranq Remedies Private Limited, buy the company report.
Comprehensive company report
Ranq Remedies Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ranq Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ranq Remedies Private Limited, buy the company report.
Financials of Ranq Remedies Private Limited
FY 2025 filings availableRanq Remedies Private Limited reported revenue of ₹51.82 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹51.82 Cr ▲ 6%
Net profit · FY 2025
₹5.05 Cr margin 9.7%
EBITDA · FY 2025
₹8.21 Cr margin 15.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 22%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 6% growth in the latest year. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ranq Remedies Private Limited, buy the company report.
Board of directors of Ranq Remedies Private Limited
Ranq Remedies has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sameer Gajanan Ranadive Also directs: Ranq Pharmaceuticals and Excipients Private Limited | Director | 20 Sep 2002 | 24 Years 1 Months | Current |
| Janhavi Bhargav Jangle Also directs: Ranq Pharmaceuticals and Excipients Private Limited | Director | 18 Jul 2013 | 13 Years 3 Months | Current |
Peer comparison
Ranq Remedies Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Om Biomedic Private Limited | ₹52.57 Cr (FY 2024) | -6.0% | Hisar, Haryana, India | |||
| Ambe Phytoextracts Private Limited | ₹52.25 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Unilab Chemicals and Pharmaceuticals Private Limited | ₹51.94 Cr (FY 2024) | 5.0% | Mumbai, Maharashtra, India | |||
| Ranq Remedies Private Limitedthis company | ₹51.82 Cr (FY 2025) | ₹5.05 Cr | 9.7% | 6.0% | 59 | Thane, Maharashtra, India |
| Vincit Labs Private Limited | ₹51.7 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Kreative Organics Private Limited | ₹50.74 Cr (FY 2023) | 6.0% | Hyderabad, Telangana, India | |||
| Vannsh Life Sciences Private Limited | ₹50.34 Cr (FY 2024) | 13.0% | Hyderabad, Telangana, India | |||
| Ultratech India Limited | ₹50.24 Cr (FY 2025) | 84.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Ranq Remedies Private Limited, buy the company report.
Auditor
Ranq Remedies Private Limited is audited by R.M. AJGAONKAR & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.M. AJGAONKAR & ASSOCIATES | FY 2024 | 117247W |
Shareholding
The shareholding of Ranq Remedies Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ranq Remedies Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹22 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Feb 2015 | 10558372 | Bank of Baroda (Senapati Bapat Road Branch) | ₹22 Cr | Satisfied |
To see the full charge records of Ranq Remedies Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Ranq Remedies Private Limited has 6 court cases on record: 3 filed by Ranq Remedies, 3 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
3
Filed against the company
3
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 3 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by M/S Roop Ultrasonix Ltd Through Jesal Yagnik | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Summons For Judgement) | Filed against the company by M/S Roop Ultrasonix Ltd Through Jesal Yagnik | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed by the company against Ankur Drugs and Pharma Ltd - Applicants - the Sarasawat Co Op Bank Ltd | Disposed |
| Bombay High Court | Company petition | Filed by the company against Kopran Limited | Disposed |
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Condation of Delay Application (ULP)) | Filed against the company by an individual | Disposed |
To see the full case history of Ranq Remedies Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ranq Remedies Private Limited was last rated by Icra on 16 Sep 2015.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 16 Sep 2015 |
To see the full credit ratings and regulatory alerts of Ranq Remedies Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ranq Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ranq Remedies Private Limited has a workforce of 59 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
59
Active EPFO establishments
1
Employee growth
7.3%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 59 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Ranq Remedies Private Limited, buy the company report.
GST
Ranq Remedies has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCR4662E1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ranq Remedies Private Limited, buy the company report.
Recent activity
Ranq Remedies Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Gauri Hemant Naiknavare ceased to be Director on 01 Jul 2014.
AGM
Ranq Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ranq Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 11 Feb 2015 via Charge ID 10558372 with Bank Of Baroda (Senapati Bapat Road Branch) was fully satisfied on 08 Mar 2021.
Charges
A charge with Bank Of Baroda (Senapati Bapat Road Branch) amounted to Rs. 2,200.00 Lakh with Charge ID 10558372 was registered on 11 Feb 2015.
Ceased
Gauri Hemant Naiknavare ceased to be Director.
Ceased
Gauri Hemant Naiknavare ceased to be Director.
Appointed
Janhavi Bhargav Jangle was appointed as Director.
Appointed
Sameer Gajanan Ranadive was appointed as Director.
Incorporation
20 Sep 2002
Ranq Remedies Private Limited was registered on 20 Sep 2002 with Roc Mumbai & aged 24 years 1 month as per MCA records.
Frequently asked questions
Ranq Remedies is an active private limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 September 2002 (24+ years old) and is registered under CIN U24230MH2002PTC137303.
Ranq Remedies has 2 current directors:
- Sameer Gajanan Ranadive - Director
- Janhavi Bhargav Jangle - Director
The latest financial statements of Ranq Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ranq Remedies is 27AACCR4662E1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ranq Remedies is U24230MH2002PTC137303. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ranq Remedies has 6 court cases on record: 3 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Ranq Remedies was incorporated on 20 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Ranq Remedies by revenue are Om Biomedic Private Limited, Ambe Phytoextracts Private Limited, Unilab Chemicals and Pharmaceuticals Private Limited, Vincit Labs Private Limited, K. A. Malle Pharmaceuticals Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gauri Hemant Naiknavare ceased to be Director on 01 Jul 2014. Gauri Hemant Naiknavare ceased to be Director on 01 Jul 2014. Janhavi Bhargav Jangle was appointed as Director on 18 Jul 2013. Ranq Remedies has 4 board changes on record in total.
Yes, Ranq Remedies is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0074559).
Ranq Remedies can be reached through the website microcellulose.com. Its registered office is in Thane, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages